Icosapent ethyl

DRUG7 trials

Conditions

Anatomic Stage IV Breast Cancer AJCC v8Aortic Valve StenosisAtherosclerosisCOVID-19Cardiovascular DiseasesColon CancerCoronary Artery DiseaseCovid19

Phase 1

Testing an Omega-3 Fatty Acid-Based Anti-Cancer Therapy for Patients With Triple-Negative Inflammatory Breast Cancer That Has Spread to Other Parts of the Body

TerminatedNCT05198843

National Cancer Institute (NCI)Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Inflammatory Carcinoma

Start: 2022-11-08End: 2023-12-20Updated: 2025-10-03

Phase 2

Pharmacodynamic Effects of a Free-Fatty Acid Formulation of Omega-3 Pentaenoic Acid in Adults With Hypertriglyceridemia

CompletedNCT04177680

Matinas BioPharma Nanotechnologies, Inc.Hypertriglyceridemia

Start: 2020-06-03End: 2021-01-18Updated: 2022-03-04

An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19

CompletedNCT04412018

Canadian Medical and Surgical Knowledge Translation Research GroupCOVID-19, Inflammatory Response

Start: 2020-06-04End: 2020-12-12Updated: 2021-12-22

IcoSApent ethyL to Slow Down Aortic VAlve Stenosis proGrEssion

Active, not recruitingNCT06466278

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Aortic Valve Stenosis

Start: 2023-06-01End: 2026-12-01Target: 110Updated: 2025-10-03

Phase 3

Effects of Eicosapentaenoic Acid on Endothelial Function in Diabetic Subjects

TerminatedNCT02422446

Brigham and Women's HospitalCoronary Artery Disease, Type 2 Diabetes

Start: 2015-04-30End: 2017-03-01Updated: 2022-03-18

EPA for Metastasis Trial 2

Active, not recruitingNCT03428477

Mark A Hull, PhD FRCPColon Cancer, Liver Metastasis

Start: 2018-05-02End: 2026-04-30Updated: 2025-04-18

Phase 4

A Pragmatic Randomized Trial of Icosapent Ethyl for High-Cardiovascular Risk Adults

TerminatedNCT04505098

Kaiser PermanenteAtherosclerosis, Cardiovascular Diseases, Covid19 +1

Start: 2020-08-07End: 2022-12-15Updated: 2023-07-18

Related Papers

Randomised, placebo-controlled, phase 3 trial of the effect of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) on colorectal cancer recurrence and survival after surgery for resectable liver metastases: EPA for Metastasis Trial 2 (EMT2) study protocol

BMJ Open2023-11-015 citations

A Head‐to‐Head Comparison of a Free Fatty Acid Formulation of Omega‐3 Pentaenoic Acids Versus Icosapent Ethyl in Adults With Hypertriglyceridemia: The ENHANCE‐IT Study

Journal of the American Heart Association2022-03-0210 citations

A randomized trial of icosapent ethyl in ambulatory patients with COVID-19

iScience2021-08-2628 citations